Dialysis prescription in acute kidney injury: when and how much?
datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
dc.contributor.author | Badel, Juan C. | |
dc.contributor.author | Garcia, Lautaro A. | |
dc.contributor.author | Soto‑Doria, Manuel J. | |
dc.contributor.author | Musso, Carlos G. | |
dc.date.accessioned | 2020-08-19T23:34:23Z | |
dc.date.available | 2020-08-19T23:34:23Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Acute kidney injury (AKI) constitutes a serious public health problem because of its very high cost and mortality rate, with an increasing incidence, phenomenon which is explained by the increasingly number of older patients suffering from several comorbidities admitted in the intensive care units. Despite the new AKI definition and classification, the use of novel AKI biomarkers and modern technologies, as an attempt to achieve an early AKI detection and treatment, and consequently to better clinical outcomes, AKI mortality particularly in ICU patients remains persistently high. In the present article, the currently accepted concepts regarding dose and time of hemodialysis and peritoneal dialysis prescription in AKI patients have been reviewed. | eng |
dc.format.mimetype | spa | |
dc.identifier.citation | Badel, J.C., Garcia, L.A., Soto-Doria, M.J. et al. Dialysis prescription in acute kidney injury: when and how much?. Int Urol Nephrol 53, 489–496 (2021). https://doi.org/10.1007/s11255-020-02601-z | eng |
dc.identifier.doi | https://doi.org/10.1007/s11255-020-02601-z | |
dc.identifier.issn | 03011623 (Impreso) | |
dc.identifier.issn | 15732584 (Electrónico) | |
dc.identifier.uri | https://hdl.handle.net/20.500.12442/6303 | |
dc.identifier.url | https://link.springer.com/article/10.1007/s11255-020-02601-z | |
dc.language.iso | eng | eng |
dc.publisher | Springer | eng |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | eng |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | International Urology and Nephrology | eng |
dc.source | Int Urol Nephrol | eng |
dc.source | Vol. 53, No. 3 (2021) | |
dc.subject | Dialysis | eng |
dc.subject | Dose | eng |
dc.subject | Prescription | eng |
dc.subject | Acute kidney injury | eng |
dc.title | Dialysis prescription in acute kidney injury: when and how much? | eng |
dc.type.driver | info:eu-repo/semantics/article | eng |
dc.type.spa | Artículo científico | spa |
dcterms.references | KDIGO (2012) Clinical practice guidelline for acute kidney injury. Kidney Int Suppl 2(1):1–38 | eng |
dcterms.references | Bellomo R, Ronco KJA, Metha RL, Palevsky P (2004) Acute Dialysis Quility initiative Workgroup. Acute renal failure-definition, outcome measure, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8(4):R204–R212 | eng |
dcterms.references | Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31 | eng |
dcterms.references | Musso CG, Terrasa S, Ciocchini M, González-Torres H, Aroca- Martínez G (2019) Looking for a better definition and diagnostic strategy for acute kidney injury: a new proposal. Arch Argent Pediatr 117(1):4–5. https ://doi.org/10.5546/aap.2019.eng.4 | eng |
dcterms.references | Koerc J, Keus F, Dieperink W, Van der Horst ICC, Zijlstra JG, Van Meurs M (2017) Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol 18:70 | eng |
dcterms.references | Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41(8):1411–1423. https ://doi. org/10.1007/s0013 4-015-3934-7 | eng |
dcterms.references | Fayad AI, Buamscha DG, Ciapponi A (2016) Intensity of continuous renal replacement therapy for acute kidney injury. Cochrane Database Syst Rev 10:CD010613 | eng |
dcterms.references | Schneider AG, Bagshaw SM (2014) Effects of renal replacement therapy on renal recovery after acute kidney injury. Nephron Clin Pract 127(1–4):35–41. https ://doi.org/10.1159/00036 3671 | eng |
dcterms.references | Negi S, Koreeda D, Kobayashi S, Yano T, Tatsuta K, Mima T, Shigematsu T, Ohya M (2018) Acute kidney injury: epidemiology, outcomes, complications, and therapeutic strategies. Semin Dial 31(5):519–527. https ://doi.org/10.1111/sdi.12705 | eng |
dcterms.references | Park JT, Lee H, Kee YK, Park S, Oh HJ, Han SH, Joo KW, Lim CS, Kim YS, Kang SW, Yoo TH, Kim DK, HICORES Investigators (2016) High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis 68(4):599–608. https ://doi.org/10.1053/j.ajkd.2016.02.049 | eng |
dcterms.references | VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 359(1):7–20. https ://doi. org/10.1056/NEJMo a0802 639 | eng |
dcterms.references | The RENAL Replacement Therapy Study Investigators (2009) Intensity of contunuos renal-replaceement therapy in critically ill patients. N Engl J Med 361:1627–1638 | eng |
dcterms.references | Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D, AKIKI Study Group (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375(2):122–133. https ://doi.org/10.1056/ NEJMo a1603 017 | eng |
dcterms.references | Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyère R, Lebert C, Bohé J, Badie J, Eraldi JP, Rigaud JP, Levy B, Siami S, Louis G, Bouadma L, Constantin JM, Mercier E, Klouche K, du Cheyron D, Piton G, Annane D, Jaber S, van der Linden T, Blasco G, Mira JP, Schwebel C, Chimot L, Guiot P, Nay MA, Meziani F, Helms J, Roger C, Louart B, Trusson R, Dargent A, Binquet C, Quenot JP, IDEAL-ICU Trial Investigators, and the CRICS TRIGGERSEP Network (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 379(15):1431–1442. https ://doi.org/10.1056/NEJMo a1803 213 | eng |
dcterms.references | Cullis B, Ponce D, Finkelstein F (2017) What Is the adequate dose for peritoneal dialysis in acute kidney injury: lower the bar or shift the goalposts? Perit Dial Int 37(5):491–493. https ://doi. org/10.3747/pdi.2017.00087 | eng |
dcterms.references | Neri M, Lorenzin A, de Cal M, Brendolan A, Marchionna N, Samoni S, Zanella M, De Rosa S, Martino F, Ricci Z, Maynar J, Auzinger G, Villa G, Payen D, Joannidis M, Ronco C (2019) Continuous renal replacement therapy platform: multicenter pilot study for technical and clinical assessment (A.M.P. Study). Blood Purif 1:1–7. https ://doi.org/10.1159/00049 6090 | eng |
dcterms.references | Romero-González G, Lorenzin A, Neri M, Ferrari F, Molano- Triviño A, Brendolan A, Ronco C (2018) Discontinuation of continuous renal replacement therapy and dialysis dependence. Contrib Nephrol 194:118–125. https ://doi.org/10.1159/00048 5609 | eng |
dcterms.references | Li P, Qu LP, Qi D, Shen B, Wang YM, Xu JR, Jiang WH, Zhang H, Ding XQ, Teng J (2017) High-dose versus low-dose haemofiltration for the treatment of critically ill patients with acute kidney injury: an updated systematic review and meta-analysis. BMJ Open 7(10):e014171. https ://doi.org/10.1136/bmjop en-2016- 01417 1 | eng |
dcterms.references | Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM (2004) Program to Improve Care in Acute Renal Disease. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 66(4):1613–1621 | eng |
dcterms.references | Zhao Y, Chen Y (2020) Effect of renal replacement therapy modalities on renal recovery and mortality for acute kidney injury: a PRISMA-compliant systematic review and meta-analysis. Semin Dial 33:127 | eng |
dcterms.references | Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, Palevsky PM, Ronco C, Saudan P, Tolwani A, Bellomo R (2018) Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis. Nephrol Dial Transpl 33(6):1017–1024. https ://doi. org/10.1093/ndt/gfx30 8 | eng |
dcterms.references | Smith OM, Wald R, Adhikari NK, Pope K, Weir MA, Bagshaw SM (2020) STandard versus accelerated initiation of renal replacement therapy in acute kidne y injury: study protocol for a multinational, multi-center, randomized controlled trial. Can J Kidney Health Dis N Engl J Med 3:240–251 | eng |
dcterms.references | Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstädt H, Boanta A, Gerß J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically Ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315(20):2190–2199. https ://doi. org/10.1001/jama.2016.5828 | eng |
oaire.version | info:eu-repo/semantics/publishedVersion | eng |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 381 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: